AI Article Synopsis

  • A 63-year-old man with a history of Crohn's disease experienced severe symptoms including malaise, weight loss, and gastrointestinal bleeding before being diagnosed with CMV infection superimposed on his Crohn's.
  • Despite starting treatment for both Crohn's and CMV, his condition worsened, leading to severe complications like pneumonia and hemophagocytic syndrome.
  • The case highlights the serious risks of CMV in patients with inflammatory bowel disease, especially those receiving immunosuppressive therapy, indicating a need for increased vigilance in such vulnerable populations.

Article Abstract

We report a case of CMV (cytomegalovirus) infection in a Crohn's disease patient, resulting in severe hemophagocytic syndrome and death. A 63-year-old man with a 10-year history of ileal and colonic Crohn's disease presented with general malaise, loss of appetite and weight loss over the last month. He was in clinical remission for two years, with maintenance therapy 5-Aminosalicylic acid (5-ASA)-derived Mesalamine. The patient had no prior immunomodulators or suppressive treatment. A colonoscopy was performed and we found appearance suggestive of active Crohn's disease, confirmed by histopathological examination. A diagnosis of an exacerbation of Crohn's disease was established. Although the specific treatment was initiated, patient's general condition degraded progressively and diarrheal stools appeared, followed by an episode of massive gastrointestinal bleeding - hematochezia. We performed a new colonoscopy and the pathological examination revealed Crohn's ileocolitis with superimposed CMV infection. Despite the initiation of Ganciclovir alongside with other intensive care measures, he increasingly deteriorated and chest X-ray confirmed multilobar pneumonia. The occurrence of rapidly progressing pancytopenia and evidence for disseminated intravascular coagulopathy as well as hyperferritinemia, raised the suspicion of hemophagocytic syndrome confirmed by bone marrow aspiration. Hence, CMV-associated hemophagocytic syndrome in the context of recent corticotherapy for Crohn's disease was established. There is enough evidence that supports the gravity of the CMV infection in the case of inflammatory bowel disease (IBD) patients, especially the ones on immunomodulator treatment. The hemophagocytic syndrome reactively occurs in patients with infections in cases of immunodeficiency, displaying a hematological aspect of multiple organ dysfunction syndrome.

Download full-text PDF

Source

Publication Analysis

Top Keywords

crohn's disease
24
hemophagocytic syndrome
20
cmv infection
12
infection crohn's
8
disease established
8
crohn's
7
disease
7
syndrome
6
hemophagocytic
5
rare complication
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!